Selected research
Industry Growth & Trends
Global Busulfan Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global Busulfan Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Busulfan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Busulfan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Busulfan Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Busulfan Injection include Nexus, Otsuka Pharmaceutical, Pharmaceutics International, Inc, China Resources Double Crane Pharmaceutical Co., Ltd., Sagent(China)Pharmaceuticals Co.,Ltd., Qingdao Haida Technology Pharmaceutical Co., Ltd. and Zhejiang Huahai Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Busulfan Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Busulfan Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Busulfan Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Busulfan Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Busulfan Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Busulfan Injection Market by Company
Nexus
Otsuka Pharmaceutical
Pharmaceutics International, Inc
China Resources Double Crane Pharmaceutical Co., Ltd.
Sagent(China)Pharmaceuticals Co.,Ltd.
Qingdao Haida Technology Pharmaceutical Co., Ltd.
Zhejiang Huahai Pharmaceutical Co., Ltd.
Busulfan Injection Segment by Type
Original Drugs
Generic Drugs
Busulfan Injection Segment by Application
Clinic
Hospital
Other
Busulfan Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Busulfan Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Busulfan Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Busulfan Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Busulfan Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Busulfan Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Original Drugs
- Generic Drugs
Applications
- Clinic
- Hospital
- Other
Companies covered
- Nexus
- Otsuka Pharmaceutical
- Pharmaceutics International, Inc
- China Resources Double Crane Pharmaceutical Co., Ltd.
- Sagent(China)Pharmaceuticals Co.,Ltd.
- Qingdao Haida Technology Pharmaceutical Co., Ltd.
- Zhejiang Huahai Pharmaceutical Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Busulfan Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Busulfan Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Busulfan Injection Market by Type
- 1.3.1 Original Drugs
- 1.3.2 Generic Drugs
- 1.4 Global Busulfan Injection Market Size by Type
- 1.4.1 Global Busulfan Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Busulfan Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Busulfan Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Busulfan Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Busulfan Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Busulfan Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Busulfan Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Busulfan Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Busulfan Injection Industry Trends
- 2.2 Busulfan Injection Industry Drivers
- 2.3 Busulfan Injection Industry Opportunities and Challenges
- 2.4 Busulfan Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Busulfan Injection Revenue (2021-2026)
- 3.2 Global Top Players by Busulfan Injection Sales (2021-2026)
- 3.3 Global Top Players by Busulfan Injection Price (2021-2026)
- 3.4 Global Busulfan Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Busulfan Injection Major Company Production Sites & Headquarters
- 3.6 Global Busulfan Injection Company, Product Type & Application
- 3.7 Global Busulfan Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Busulfan Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Busulfan Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Busulfan Injection Tier 1, Tier 2, and Tier 3
4 Busulfan Injection Regional Status and Outlook
- 4.1 Global Busulfan Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Busulfan Injection Historic Market Size by Region
- 4.2.1 Global Busulfan Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Busulfan Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Busulfan Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Busulfan Injection Forecasted Market Size by Region
- 4.3.1 Global Busulfan Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Busulfan Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Busulfan Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Busulfan Injection by Application
- 5.1 Busulfan Injection Market by Application
- 5.1.1 Clinic
- 5.1.2 Hospital
- 5.1.3 Other
- 5.2 Global Busulfan Injection Market Size by Application
- 5.2.1 Global Busulfan Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Busulfan Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Busulfan Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Busulfan Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Busulfan Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Busulfan Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Busulfan Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Busulfan Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Nexus
- 6.1.1 Nexus Company Information
- 6.1.2 Nexus Business Overview
- 6.1.3 Nexus Busulfan Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Nexus Busulfan Injection Product Portfolio
- 6.1.5 Nexus Recent Developments
- 6.2 Otsuka Pharmaceutical
- 6.2.1 Otsuka Pharmaceutical Company Information
- 6.2.2 Otsuka Pharmaceutical Business Overview
- 6.2.3 Otsuka Pharmaceutical Busulfan Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Otsuka Pharmaceutical Busulfan Injection Product Portfolio
- 6.2.5 Otsuka Pharmaceutical Recent Developments
- 6.3 Pharmaceutics International, Inc
- 6.3.1 Pharmaceutics International, Inc Company Information
- 6.3.2 Pharmaceutics International, Inc Business Overview
- 6.3.3 Pharmaceutics International, Inc Busulfan Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Pharmaceutics International, Inc Busulfan Injection Product Portfolio
- 6.3.5 Pharmaceutics International, Inc Recent Developments
- 6.4 China Resources Double Crane Pharmaceutical Co., Ltd.
- 6.4.1 China Resources Double Crane Pharmaceutical Co., Ltd. Company Information
- 6.4.2 China Resources Double Crane Pharmaceutical Co., Ltd. Business Overview
- 6.4.3 China Resources Double Crane Pharmaceutical Co., Ltd. Busulfan Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 China Resources Double Crane Pharmaceutical Co., Ltd. Busulfan Injection Product Portfolio
- 6.4.5 China Resources Double Crane Pharmaceutical Co., Ltd. Recent Developments
- 6.5 Sagent(China)Pharmaceuticals Co.,Ltd.
- 6.5.1 Sagent(China)Pharmaceuticals Co.,Ltd. Company Information
- 6.5.2 Sagent(China)Pharmaceuticals Co.,Ltd. Business Overview
- 6.5.3 Sagent(China)Pharmaceuticals Co.,Ltd. Busulfan Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Sagent(China)Pharmaceuticals Co.,Ltd. Busulfan Injection Product Portfolio
- 6.5.5 Sagent(China)Pharmaceuticals Co.,Ltd. Recent Developments
- 6.6 Qingdao Haida Technology Pharmaceutical Co., Ltd.
- 6.6.1 Qingdao Haida Technology Pharmaceutical Co., Ltd. Company Information
- 6.6.2 Qingdao Haida Technology Pharmaceutical Co., Ltd. Business Overview
- 6.6.3 Qingdao Haida Technology Pharmaceutical Co., Ltd. Busulfan Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Qingdao Haida Technology Pharmaceutical Co., Ltd. Busulfan Injection Product Portfolio
- 6.6.5 Qingdao Haida Technology Pharmaceutical Co., Ltd. Recent Developments
- 6.7 Zhejiang Huahai Pharmaceutical Co., Ltd.
- 6.7.1 Zhejiang Huahai Pharmaceutical Co., Ltd. Company Information
- 6.7.2 Zhejiang Huahai Pharmaceutical Co., Ltd. Business Overview
- 6.7.3 Zhejiang Huahai Pharmaceutical Co., Ltd. Busulfan Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Zhejiang Huahai Pharmaceutical Co., Ltd. Busulfan Injection Product Portfolio
- 6.7.5 Zhejiang Huahai Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
- 7.1 North America Busulfan Injection Sales by Country
- 7.1.1 North America Busulfan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Busulfan Injection Sales by Country (2021-2026)
- 7.1.3 North America Busulfan Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Busulfan Injection Market Size by Country
- 7.2.1 North America Busulfan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Busulfan Injection Market Size by Country (2021-2026)
- 7.2.3 North America Busulfan Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Busulfan Injection Sales by Country
- 8.1.1 Europe Busulfan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Busulfan Injection Sales by Country (2021-2026)
- 8.1.3 Europe Busulfan Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Busulfan Injection Market Size by Country
- 8.2.1 Europe Busulfan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Busulfan Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Busulfan Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Busulfan Injection Sales by Country
- 9.1.1 Asia-Pacific Busulfan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Busulfan Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Busulfan Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Busulfan Injection Market Size by Country
- 9.2.1 Asia-Pacific Busulfan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Busulfan Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Busulfan Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Busulfan Injection Sales by Country
- 10.1.1 South America Busulfan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Busulfan Injection Sales by Country (2021-2026)
- 10.1.3 South America Busulfan Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Busulfan Injection Market Size by Country
- 10.2.1 South America Busulfan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Busulfan Injection Market Size by Country (2021-2026)
- 10.2.3 South America Busulfan Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Busulfan Injection Sales by Country
- 11.1.1 Middle East and Africa Busulfan Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Busulfan Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Busulfan Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Busulfan Injection Market Size by Country
- 11.2.1 Middle East and Africa Busulfan Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Busulfan Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Busulfan Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Busulfan Injection Value Chain Analysis
- 12.1.1 Busulfan Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Busulfan Injection Production Mode & Process
- 12.2 Busulfan Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Busulfan Injection Distributors
- 12.2.3 Busulfan Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst